These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 37353117)
1. Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review. Wang Y; Yang K; Zhou H Int J Biol Macromol; 2023 Aug; 245():125515. PubMed ID: 37353117 [TBL] [Abstract][Full Text] [Related]
2. Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus. Ye T; Zhou J; Guo C; Zhang K; Wang Y; Liu Y; Zhou J; Xie Y; Li E; Gong R; Zhang J; Chuai X; Chiu S Cell Rep; 2024 Jun; 43(6):114269. PubMed ID: 38787725 [TBL] [Abstract][Full Text] [Related]
3. Rational development of multicomponent mRNA vaccine candidates against mpox. Zhang RR; Wang ZJ; Zhu YL; Tang W; Zhou C; Zhao SQ; Wu M; Ming T; Deng YQ; Chen Q; Jin NY; Ye Q; Li X; Qin CF Emerg Microbes Infect; 2023 Dec; 12(1):2192815. PubMed ID: 36947428 [TBL] [Abstract][Full Text] [Related]
4. Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge. Tang D; Liu X; Lu J; Fan H; Xu X; Sun K; Wang R; Li C; Dan D; Du H; Wang Z; Li X; Yang X Front Immunol; 2023; 14():1203410. PubMed ID: 37435062 [TBL] [Abstract][Full Text] [Related]
5. A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice. Yang X; Yang X; Du S; Hu C; Yang X; Wang X; Hu X; Rcheulishvili N; Wang PG; Lin J Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766097 [TBL] [Abstract][Full Text] [Related]
6. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus. Li E; Guo X; Hong D; Gong Q; Xie W; Li T; Wang J; Chuai X; Chiu S Signal Transduct Target Ther; 2023 Sep; 8(1):350. PubMed ID: 37709783 [TBL] [Abstract][Full Text] [Related]
7. Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. Sang Y; Zhang Z; Liu F; Lu H; Yu C; Sun H; Long J; Cao Y; Mai J; Miao Y; Wang X; Fang J; Wang Y; Huang W; Yang J; Wang S Signal Transduct Target Ther; 2023 Apr; 8(1):172. PubMed ID: 37117161 [TBL] [Abstract][Full Text] [Related]
8. Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus. Li M; Ren Z; Wang Y; Jiang Y; Yang M; Li D; Chen J; Liang Z; Lin Y; Zeng Z; Xu R; Wang Y; Zhu L; Xiao W; Wu Q; Zhang B; Wan C; Yang Y; Wu B; Peng J; Zhao W; Shen C Emerg Microbes Infect; 2023 Dec; 12(2):2223669. PubMed ID: 37288876 [TBL] [Abstract][Full Text] [Related]
9. Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice. Xia H; He YR; Zhan XY; Zha GF Antiviral Res; 2023 Aug; 216():105668. PubMed ID: 37429529 [TBL] [Abstract][Full Text] [Related]
10. Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches. Tan C; Zhu F; Pan P; Wu A; Li C Front Immunol; 2023; 14():1112816. PubMed ID: 36993967 [TBL] [Abstract][Full Text] [Related]
11. Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice. Yang X; Hu C; Yang X; Yang X; Hu X; Wang X; Liu C; Yuan Y; Du S; Wang PG; Lin J J Med Virol; 2023 Oct; 95(10):e29140. PubMed ID: 37800627 [TBL] [Abstract][Full Text] [Related]
12. In silico development of a novel anti-mutation, multi-epitope mRNA vaccine against MPXV variants of emerging lineage and sub-lineages by using immunoinformatics approaches. Tan C; Zhou J; Wu A; Li C J Biomol Struct Dyn; 2024 Mar; ():1-18. PubMed ID: 38450722 [TBL] [Abstract][Full Text] [Related]
13. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study. Cohn H; Bloom N; Cai GY; Clark JJ; Tarke A; Bermúdez-González MC; Altman DR; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Yates JL; Hunt DT; Lee WT; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH Lancet Infect Dis; 2023 Nov; 23(11):1302-1312. PubMed ID: 37475115 [TBL] [Abstract][Full Text] [Related]
14. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus. Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141 [TBL] [Abstract][Full Text] [Related]
15. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development. Andrei G; Snoeck R Trends Pharmacol Sci; 2023 Oct; 44(10):719-739. PubMed ID: 37673695 [TBL] [Abstract][Full Text] [Related]
17. Analysis of binding and authentic virus-neutralizing activities of immune sera induced by various monkeypox virus antigens. Song S; Ren Z; Chen J; Li M; Jiang Y; Liu Y; Zhang B; Lu H; Zhao W; Shen C; Yang Y Immunol Res; 2024 Jun; ():. PubMed ID: 38829493 [TBL] [Abstract][Full Text] [Related]
18. Proteomics-based vaccine targets annotation and design of subunit and mRNA-based vaccines for Monkeypox virus (MPXV) against the recent outbreak. Jin Y; Fayyaz A; Liaqat A; Khan A; Alshammari A; Wang Y; Gu RX; Wei DQ Comput Biol Med; 2023 Jun; 159():106893. PubMed ID: 37116237 [TBL] [Abstract][Full Text] [Related]
19. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans. Grifoni A; Zhang Y; Tarke A; Sidney J; Rubiro P; Reina-Campos M; Filaci G; Dan JM; Scheuermann RH; Sette A Cell Host Microbe; 2022 Dec; 30(12):1662-1670.e4. PubMed ID: 36463861 [TBL] [Abstract][Full Text] [Related]